Atlas Trials

Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

Clinical trial NCT07351266 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07351266
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Renal Cell Carcinoma (Kidney Cancer)
Start date
2026-01-25
Primary completion
2028-01-25
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.